Palisade Bio (PALI) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -45.96% |
| Mar 31, 2025 | -42.25% |
| Dec 31, 2024 | -40.74% |
| Sep 30, 2024 | -43.46% |
| Jun 30, 2024 | -42.46% |
| Mar 31, 2024 | -41.92% |
| Dec 31, 2023 | -35.61% |
| Sep 30, 2023 | -37.77% |
| Jun 30, 2023 | -38.79% |
| Mar 31, 2023 | -43.01% |
| Dec 31, 2022 | -43.45% |
| Sep 30, 2022 | -42.81% |
| Jun 30, 2022 | -60.92% |
| Mar 31, 2022 | -61.70% |
| Dec 31, 2021 | -59.33% |
| Sep 30, 2021 | -60.59% |
| Jun 30, 2021 | -61.68% |
| Mar 31, 2021 | -53.61% |
| Dec 31, 2020 | -57.08% |
| Sep 30, 2020 | -46.27% |
| Jun 30, 2020 | -42.43% |
| Mar 31, 2020 | -35.65% |
| Dec 31, 2019 | -32.88% |
| Sep 30, 2019 | -29.64% |
| Jun 30, 2019 | -27.19% |
| Mar 31, 2019 | -24.59% |
| Dec 31, 2018 | -17.12% |
| Sep 30, 2018 | -15.82% |
| Jun 30, 2018 | -7.58% |
| Mar 31, 2018 | -6.34% |
| Dec 31, 2017 | -5.58% |
| Sep 30, 2017 | -4.43% |
| Jun 30, 2017 | -4.03% |
| Mar 31, 2017 | -1.84% |
| Dec 31, 2016 | -1.60% |
| Sep 30, 2016 | 0.20% |
| Jun 30, 2016 | 1.58% |
| Dec 31, 2015 | 11.40% |